MY152146A - Hydroxybenzoate salts of metanicotine compounds - Google Patents

Hydroxybenzoate salts of metanicotine compounds

Info

Publication number
MY152146A
MY152146A MYPI20070724A MY152146A MY 152146 A MY152146 A MY 152146A MY PI20070724 A MYPI20070724 A MY PI20070724A MY 152146 A MY152146 A MY 152146A
Authority
MY
Malaysia
Prior art keywords
metanicotine
compounds
hydroxybenzoate salts
hydroxybenzoate
salts
Prior art date
Application number
Inventor
Julio A Munoz
Genus John
James R Moore
Original Assignee
Targacept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targacept Inc filed Critical Targacept Inc
Priority to MYPI20070724 priority Critical patent/MY152146A/en
Publication of MY152146A publication Critical patent/MY152146A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PATIENTS SUSCEPTIBLE TO OR SUFFERING FROM CONDITIONS AND DISORDERS, SUCH AS CENTRAL NERVOUS SYSTEM DISORDERS, ARE TREATED BY ADMINISTERING TO A PATIENT IN NEED THEREOF COMPOSITIONS THAT ARE HYDROXYBENZOATE SALTS OF E-METANICOTINE-TYPE COMPOUNDS. THE FORMATION OF HYDROXYBENZOATE SALTS OF THE E-METANICOTINE COMPOUNDS IS ALSO USEFUL IN PURIFYING THE E-METANICOTINE COMPOUNDS, AS THE HYDROXYBENZOATE SALTS TEND TO CRYSTALLIZE OUT, LEAVING IMPURITIES SUCH AS Z-METANICOTINE COMPOUNDS, AND COMPOUNDS WHERE THE DOUBLE BOND HAS MIGRATED, IN SOLUTION. IF DESIRED, THE HYDROXYBENZOATE SALTS CAN BE CONVERTED TO EITHER THE FREE BASE (THE E-METANICOTINE) OR TO ANOTHER PHARMACEUTICALLY ACCEPTABLE SALT FORM.
MYPI20070724 2007-05-10 2007-05-10 Hydroxybenzoate salts of metanicotine compounds MY152146A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20070724 MY152146A (en) 2007-05-10 2007-05-10 Hydroxybenzoate salts of metanicotine compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20070724 MY152146A (en) 2007-05-10 2007-05-10 Hydroxybenzoate salts of metanicotine compounds

Publications (1)

Publication Number Publication Date
MY152146A true MY152146A (en) 2014-08-15

Family

ID=52595854

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20070724 MY152146A (en) 2007-05-10 2007-05-10 Hydroxybenzoate salts of metanicotine compounds

Country Status (1)

Country Link
MY (1) MY152146A (en)

Similar Documents

Publication Publication Date Title
SG157379A1 (en) Hydroxybenzoate salts of metanicotine compounds
MX2010004026A (en) Substituted piperidino-dihydrothienopyrimidines.
UA102541C2 (en) 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor
TN2011000437A1 (en) Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
MX2009011755A (en) Combination therapy with a compound acting as a platelet adp receptor inhibitor.
UA86614C2 (en) Compound having kinase ingibitor activity, pharmaceutical composition containing thereof and use thereof for the preparation of medicine
TW200806300A (en) New therapeutic combinations for the treatment of depression
MX2014000536A (en) 4 - piperidinyl compounds for use as tankyrase inhibitors.
MY144132A (en) Polymorph forms of (2s)-(4e)-n-methyl-5-[3-(5-isoproproxypyridin)yl]-4-penten-2-amine
MX2010002565A (en) Substituted 6-pheylnicotinic acids and the use thereof.
TW200736213A (en) Dicarboxylic acid derivatives and their use
MY167396A (en) Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament
ATE538100T1 (en) AMINOTETRAHYDROINDAZOLOACETIC ACIDS
TW200621765A (en) Substituted phenylaminothiazoles and their use
MX2011010732A (en) Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease.
PH12012501863A1 (en) 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
PL2244703T3 (en) The drug, its manufacture and use in the treatment of painful neuropathies
IL195016A0 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
IL178122A0 (en) Materials and methods for treating coagulation disorders
DE602007014193D1 (en) TREATMENT OF PSYCHIATRIC PATIENTS WITH SLEEP DISORDERS AND / OR EXCESSIVE TAGESSLESSNESS WITH PALIPERIDONE
IL206615A (en) Piperidine sulfonamide derivatives, process for their preparation, medicaments containing them and use thereof for the preparation of medicaments for therapy
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure
EA201170736A1 (en) SYNTHESIS AND NEW SALT SHAPES
PH12022552763A1 (en) Medical use of daridorexant
MX2015009268A (en) Isometheptene isomer.